Journal of Clinical Apheresis

Papers
(The TQCC of Journal of Clinical Apheresis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Mobilization with high‐dose granulocyte colony‐stimulating factor alone at 12 μg/kg twice a day in high‐risk pediatric patients: A retrospective analysis of the experience in a single center270
18
18
Issue Information16
Role of automated red blood cell exchange in the treatment of aluminum phosphide poisoning: A case report and review of the literature14
Analysis of responses of the health care workers recovered from COVID‐19 on convalescent plasma donation by apheresis: A single‐center survey study11
Algorithm‐based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease10
The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts10
9
Impact of saline infusion as replacement fluid at donor plasmapheresis9
Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report9
Impact of saline infusion and citrate infusion rate during donor plasmapheresis9
8
Issue Information8
A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry8
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO‐incompatible hematopoietic stem cell transplant7
7
Issue Information7
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)7
A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio7
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies7
Issue Information7
Writing manuscripts for peer review6
A retrospective study for association between post‐transfusion hemoglobin S level and pre‐transfusion hemoglobin S level at the next scheduled transfusion6
Issue Information6
Therapeutic plasma exchange for multiorgan dysfunction among critically ill pediatric patients with leukemia: A single‐institutional experience5
Issue Information5
Central venous catheters are associated with thrombosis among adult inpatients undergoing therapeutic plasma exchange5
Addition of plerixafor in poorly mobilized allogeneic stem cell donors5
Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease5
No increase in anti‐A isohemagglutinin titer after SARS‐CoV‐2 infection: A retrospective cohort analysis of group O apheresis platelet donors5
Apheresis practice patterns in the United States of America: Analysis of a market claims database4
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series4
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children4
CD34+ cell yield among healthy donors: Large‐scale model development and validation4
Telapheresis: One institution's experience4
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial4
4
I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India4
Suspected autoimmune encephalitis: A retrospective study of patients referred for therapeutic plasma exchange4
Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis4
Therapeutic plasma exchange for mechanical red cell hemolysis: A case series4
Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot st4
What's in a Name: Your PLEX or PEX Is Our TPE4
Apheresis practice variation during the COVID‐19 pandemic: Results of a survey4
Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor3
Single center experience of therapeutic plasma exchange in a resource‐constrained setting: A study of trends in scope and complications3
3
Comparison of hematopoietic progenitor cell collection using different inlet flow rates with the Fenwal Amicus3
The efficiency of a continuous versus an intermittent apheresis method for collection of hematopoietic progenitor stem cells: A systematic review3
Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors3
Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO‐incompatible liver transplant3
Therapeutic plasma exchange for life‐threatening pediatric disorders3
Therapeutic plasma exchange in adolescent and adult patients with autoimmune neuropsychiatric disorders associated with streptococcal infections3
Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34+ cell counts differs according to diagnosis in patients undergoing au3
Comparison of procedure times and collection efficiencies using integrated and multistep nonintegrated procedures for extracorporeal photopheresis3
Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study3
3
Comparison of Adverse Reactions With Solvent/Detergent Treated Plasma Versus Untreated Plasma Use in Therapeutic Plasma Exchange in Pediatric Patients3
Safety and efficacy of peripheral blood stem cells collection in healthy children and pediatric patients with thalassemia major weighing 20 kg or less3
Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases3
Vascular access for autologous peripheral blood stem cells collection by large volume leukapheresis: Single center experience3
Comment on “Donor tolerability of convalescent plasma donation”2
Crude collection efficiency of CD34+ hematopoietic stem cell apheresis2
Modifications to therapeutic plasma exchange to achieve rapid exchange on cardiopulmonary bypass prior to pediatric cardiac transplant2
Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection2
2
2
Special Issue Abstracts from the American Society for Apheresis 44th Annual Meeting April 26–28, 20232
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor2
COVID‐19‐associated transverse myelitis treated by therapeutic plasma exchange: A case report2
Evaluation of safety of using incompatible plasma for therapeutic plasma exchange during shortage of AB plasma2
High D‐index during mobilization predicts poor mobilization ofCD34+ cells after anti‐lymphoma salvage chemotherapy2
Safety and performance of theSpectraOptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts2
Botulism mimicking Guillain‐Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis2
Severe complications in a 25‐year‐old male after brown recluse spider bite treated by therapeutic plasma exchange: A case report and review of other case studies2
Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease2
Legendary Case of Factitious Disorder Presenting as ‘Sickle Cell Disease’ Creates Challenges for All Medical Specialties2
Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low‐body weight child: A case report2
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean‐Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and2
Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients2
Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/−plerixafor vs cyclophosphamide/GCSF2
Issue Information2
Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study2
Real‐world evidence of heparin and citrate use in extracorporeal photopheresis: A hypothesis‐generating data review of device settings and performance2
Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease2
Impact of Covid‐19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendations and global perspectives2
A rare case of acute cerebellitis due to enterovirus treated with therapeutic plasma exchange: Case report and review of the literature2
Francis S. Morrison MD—Tribute to an apheresis leader2
MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitis2
Special Issue Abstracts From the American Society for Apheresis 43rd Annual Meeting May 4–6, 2022 Philadelphia, Pennsylvania2
Effects of central catheter recirculation during extracorporeal photopheresis2
Massive bee envenomation treated by therapeutic plasma exchange2
Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited2
0.35740900039673